|
|
|
Insider
Information: |
Baker Felix |
Relationship: |
Director, 10% Owner |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
20 |
|
Direct
Shares |
927,207 |
|
Indirect Shares
|
141,861,898 |
|
|
Direct
Value |
$84,919,510 |
|
|
Indirect Value
|
$13,116,072,593 |
|
|
Total
Shares |
142,789,105 |
|
|
Total
Value |
$13,200,992,103 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
36
|
6
|
Stock
price went up :
|
15
|
6
|
Stock
price went down : |
21
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
6.0
|
Percentage
Gain/Loss : |
-24.3%
|
18.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Incyte Corp |
INCY |
Director, 10% Owner |
2023-09-29 |
559,963 |
2023-09-29 |
33,480,292 |
Premium* |
|
Ardea Biosciences Inc |
RDEA |
Director, 10% Owner |
2003-10-06 |
0 |
2012-02-01 |
116,454 |
Premium* |
|
Seagen Inc |
SGEN |
Director, 10% Owner |
2018-02-01 |
215,015 |
2018-02-01 |
44,355,335 |
Premium* |
|
Synageva BioPharma Corp |
GEVA |
Director, 10% Owner |
2015-06-22 |
100,503 |
2015-06-22 |
9,328,233 |
Premium* |
|
Viropharma Inc |
VPHM |
10% Owner |
2005-01-31 |
0 |
2011-12-14 |
303,264 |
Premium* |
|
Aceragen, Inc |
ACGN |
Director |
|
0 |
2017-07-03 |
145,453 |
Premium* |
|
Tapestry Pharmaceuticals Inc |
TPPHQ |
10% Owner |
|
0 |
2008-10-15 |
0 |
Premium* |
|
Genomic Health Inc |
GHDX |
Director, 10% Owner |
2012-10-01 |
288 |
2012-10-01 |
11,377,485 |
Premium* |
|
Allos Therapeutics Inc |
ALTH |
10% Owner |
|
0 |
2009-02-06 |
1,629 |
Premium* |
|
Biocryst Pharmaceuticals Inc |
BCRX |
10% Owner |
2016-08-16 |
46,918 |
2016-08-16 |
9,418,390 |
Premium* |
|
Heron Therapeutics Inc |
HRTX |
10% Owner |
|
0 |
2011-06-30 |
5,266,568 |
Premium* |
|
Adolor Corp |
ADLR |
10% Owner |
2010-04-26 |
0 |
2011-12-19 |
0 |
Premium* |
|
Diadexus Inc |
DDXS |
10% Owner |
|
0 |
2010-07-28 |
140,525 |
Premium* |
|
Pharmacyclics Inc |
PCYC |
10% Owner |
|
0 |
2011-08-22 |
1,809 |
Premium* |
|
Ocera Therapeutics Inc |
OCRX |
10% Owner |
2012-03-12 |
0 |
2012-03-14 |
57,704 |
Premium* |
|
XOMA Corporation |
XOMA |
Director, 10% Owner |
2012-10-29 |
0 |
2012-10-29 |
480,639 |
Premium* |
|
Neurogene |
NGNE |
10% Owner |
2015-08-07 |
4,520 |
|
0 |
Premium* |
|
Invitae Corp |
NVTA |
10% Owner |
|
0 |
2015-08-27 |
6,554,967 |
Premium* |
|
Bellicum Pharmaceuticals, Inc |
BLCM |
10% Owner |
|
0 |
2015-12-24 |
4,865,647 |
Premium* |
|
Kodiak Sciences Inc. |
KOD |
Director, 10% Owner |
2022-01-21 |
0 |
2022-06-06 |
15,967,504 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
1397 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 8 of 56
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
RDEA |
Ardea Biosciences Inc |
10% Owner |
|
2003-10-06 |
4 |
B |
$10.80 |
$356,940 |
I/I |
33,050 |
39,732 |
1.5 |
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2008-07-29 |
4 |
S |
$14.93 |
$28,145 |
I/I |
(1,885) |
40,077 |
0 |
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2007-10-31 |
4 |
S |
$11.70 |
$8,783 |
I/I |
(751) |
40,189 |
0 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2004-08-04 |
4 |
B |
$5.58 |
$92,368 |
I/I |
16,557 |
40,793 |
2.25 |
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2007-10-30 |
4 |
S |
$12.03 |
$11,980 |
I/I |
(996) |
40,940 |
0 |
- |
|
TPPHQ |
Tapestry Pharmaceuticals ... |
10% Owner |
|
2008-04-03 |
4 |
S |
$0.11 |
$58 |
I/I |
(521) |
41,120 |
0 |
- |
|
RDEA |
Ardea Biosciences Inc |
10% Owner |
|
2004-03-15 |
4 |
B |
$16.11 |
$13,729 |
I/I |
852 |
41,300 |
1.5 |
- |
|
TPPHQ |
Tapestry Pharmaceuticals ... |
10% Owner |
|
2006-04-05 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
41,641 |
|
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2007-10-29 |
4 |
S |
$12.47 |
$13,290 |
I/I |
(1,066) |
41,936 |
0 |
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2008-07-28 |
4 |
S |
$14.87 |
$8,403 |
I/I |
(565) |
41,962 |
0 |
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2008-07-25 |
4 |
S |
$15.01 |
$26,541 |
I/I |
(1,768) |
42,527 |
0 |
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2007-06-20 |
4 |
S |
$7.38 |
$863 |
I/I |
(117) |
42,885 |
0 |
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2007-06-20 |
4 |
B |
$7.30 |
$854 |
I/I |
117 |
43,002 |
1.42 |
- |
|
RDEA |
Ardea Biosciences Inc |
10% Owner |
|
2007-12-19 |
4 |
B |
$13.25 |
$317,576 |
I/I |
23,968 |
43,108 |
1.5 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2005-04-29 |
4 |
B |
$3.99 |
$58,933 |
I/I |
14,734 |
43,868 |
2.25 |
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2008-07-24 |
4 |
S |
$15.02 |
$44,267 |
I/I |
(2,947) |
44,295 |
0 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2005-05-04 |
4 |
B |
$4.79 |
$5,853 |
I/I |
1,222 |
45,090 |
2.17 |
- |
|
BCRX |
Biocryst Pharmaceuticals ... |
10% Owner |
|
2015-11-06 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
46,918 |
|
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2008-07-23 |
4 |
S |
$14.86 |
$28,024 |
I/I |
(1,886) |
47,242 |
0 |
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2006-02-27 |
4 |
S |
$21.58 |
$469,825 |
I/I |
(21,633) |
47,428 |
|
- |
|
RDEA |
Ardea Biosciences Inc |
10% Owner |
|
2004-10-13 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
48,266 |
|
- |
|
SGEN |
Seagen Inc |
Director |
|
2005-04-29 |
4 |
B |
$3.99 |
$46,166 |
I/I |
11,542 |
48,859 |
2.25 |
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2008-07-17 |
4 |
S |
$14.80 |
$52,318 |
I/I |
(3,535) |
49,128 |
0 |
- |
|
RDEA |
Ardea Biosciences Inc |
10% Owner |
|
2005-04-12 |
4 |
B |
$3.57 |
$689 |
I/I |
193 |
49,200 |
1.42 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2005-05-04 |
4 |
B |
$4.79 |
$4,541 |
I/I |
948 |
49,807 |
2.17 |
- |
|
1397 Records found
|
|
Page 8 of 56 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|